MYC and B-cell non-Hodgkin lymphoma: The studies of Chk1 inhibitor resistance performed their experiments using a mouse model of lymphoma called Eμ-Myc, a common model of B-cell lymphoma in which the oncogene Myc is overexpressed [4].